Some brotherhoods are forged in shared passions, others in circumstance. For the Boozer family, a bond deepened by a son’s diagnosis with a life-threatening illness led to an extraordinary medical journey and, the birth of two siblings with a singular purpose: to save his life. The story is a testament to the lengths a family will go to for one another and the rapidly evolving possibilities within reproductive medicine.
Carmani Boozer, son of former NBA player Carlos Boozer, was born with Sickle Cell Disease, a genetic blood disorder that can cause severe pain, organ damage, and a shortened lifespan. The most promising path toward a cure for Carmani was a stem cell transplant, ideally from a perfectly matched sibling. Although, both Carlos and his wife, CeCe, carried the sickle cell trait, meaning there was a 25% chance with each pregnancy that their child would inherit the disease, a 25% chance of being a carrier like themselves, and a 50% chance of being unaffected. Finding a matched donor outside the family proved challenging, highlighting the critical need for increased diversity in stem cell registries.
Faced with limited options, the Boozers turned to a complex and relatively uncommon approach: preimplantation genetic diagnosis (PGD) combined with in vitro fertilization (IVF). This process allowed them to screen embryos for the sickle cell gene before implantation, increasing the chances of having a child who could serve as a donor for Carmani. According to the National Institutes of Health, PGD is used to identify genetic defects in embryos created through IVF, allowing parents to select embryos that are free of the condition. Learn more about PGD from the NIH.
A Unique IVF Journey
The Boozers’ journey wasn’t simply about identifying a healthy embryo; it required finding one that was a perfect match for Carmani. CeCe Boozer underwent ovarian stimulation to produce multiple eggs. A total of 34 eggs were harvested, and ten were successfully fertilized. These embryos were then tested to determine their genetic makeup. Remarkably, only two embryos were found to be both free of the sickle cell gene and a complete HLA (human leukocyte antigen) match for Carmani – meaning they were the most likely to be accepted by his body and provide a successful transplant.
Those two embryos developed into Cameron and Cayden Boozer, twins born with the explicit purpose of potentially saving their older brother’s life. The decision to pursue this path was deeply personal and involved extensive ethical considerations, as Carlos Boozer explained in interviews. The family openly discussed the weight of expectation placed on the twins, emphasizing the importance of allowing them to live full and independent lives, regardless of whether they ultimately became donors.
Carmani’s Progress and the Twins’ Future
Years later, Carmani Boozer is thriving. He recently completed a season playing baseball at the University of Fort Lauderdale, demonstrating a resilience and determination that his family attributes, in part, to the support he’s received. While a transplant hasn’t yet been necessary, the possibility remains open, and Cameron and Cayden remain potential donors. The family has been vocal about the importance of continued research into sickle cell disease and the need for increased access to potentially curative treatments.
Meanwhile, Cameron and Cayden are charting their own paths, with both expected to follow in their father’s footsteps and pursue basketball. Carlos Boozer, who enjoyed a successful 13-year NBA career, has expressed his pride in his sons and their dedication to the sport. Carlos Boozer’s NBA profile can be found on NBA.com. The family’s story has garnered attention for its unique circumstances and the ethical questions it raises about reproductive technology and the creation of “savior siblings.”
The Ethics of PGD and “Savior Siblings”
The Boozers’ case highlights the complex ethical landscape surrounding PGD. While the technology offers hope for families facing genetic diseases, it also raises concerns about the potential for “designer babies” and the commodification of human life. Bioethicists have debated the morality of selecting embryos based on their genetic compatibility with an existing child, questioning whether it places undue pressure on the donor sibling and potentially diminishes their autonomy.
However, proponents of PGD argue that it is a legitimate and ethical use of technology when it is used to prevent serious genetic diseases and provide a life-saving opportunity for a child in need. The Boozers’ decision was made with careful consideration and a deep commitment to their son’s well-being. The case underscores the need for ongoing dialogue and ethical guidelines to ensure that these technologies are used responsibly and with respect for all involved.
The Boozer family’s story is a powerful illustration of the intersection of love, loss, and medical innovation. It’s a reminder that the pursuit of health and healing can sometimes lead families down unexpected paths, and that the bonds of brotherhood can be forged in the most extraordinary of circumstances. The family continues to advocate for increased awareness and funding for sickle cell disease research, hoping to improve the lives of others affected by this challenging condition.
Looking ahead, the Boozer family remains focused on supporting Carmani’s athletic pursuits and monitoring his health. Further advancements in gene therapy and stem cell research offer promising new avenues for treating sickle cell disease, potentially reducing the need for donor transplants in the future. The family plans to remain actively involved in the sickle cell community, sharing their experiences and advocating for improved access to care.
If you’d like to learn more about sickle cell disease, or support research efforts, please visit the Sickle Cell Disease Association of America. We encourage readers to share this story and join the conversation about the ethical and medical implications of preimplantation genetic diagnosis.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
